Voglibose
Product Name : Voglibose
Grade : IP / BP / USP
Therapeutic Category : Antidiabetic
CAS No : 83480-29-9
COA : Available
MSDS : Available
Description
Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. Voglibose delays the absorption of glucose thereby reducing the risk of macrovascular complications.
Apperance: white crystalline powder
Specification
- Appearance White to almost white powder
- Solubility ———-
- Melting point 163~168°C
- Specific Rotation +45°~ +48°
- Identification
- 1) The IR absorption spectrum of the sample is concordant with that of Voglibose reference standard
- 2) HPLC
- Acidity 9.4 ~10.4
- Related Substances(HPLC) Total impurity≤0.2%
- Water ≤0.5%
- Residue on ignition ≤0.2%
- Heavy metals ≤10ppm
- Assay(on dried basis) 99.5%-101.0%
Packaging details
Packaging details: 25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.
Storage: Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat.
Shelf Life: 5 years if sealed and store away from direct sun light.
Additional Information
The most widely recognized markets for this item incorporate the accompanying nations. If you don’t mind ask with us if your nation or district isn’t recorded:
ASIA: Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Afghanistan, Israel, Jordan, Pakistan, Russia, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth..
AFRICA: South Africa, Uganda, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, and so forth.
NORTH & SOUTH AMERICA: Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela, USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Brazil, Bahamas, Ecuador, and so forth .
EUROPE: France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Austria, Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.
OCEANIA: Fiji, Australia, New Zealand, and so forth.
© Chemconpharma | Created By by TechRhombus